With a new chief executive set to take charge this spring, Shire Plc has settled two outstanding lawsuits and started to broaden its specialist medicines portfolio. Flemming Ørnskov of Bayer AG will take over as CEO on 30 April, succeeding Angus Russell, who is retiring.
